#clinical trial

Health equity advocate Karen Winkfield, MD, MPH, works to enroll more underserved people with cancer in lifesaving clinical trials.

Certain racial/ethnic groups and older people aren’t being adequately represented and trial reporting guidelines aren’t being followed.

Eventual vaccination of children will be crucial to subduing the COVID virus, but pediatricians are split on how fast to move toward that.

The Senate-passed bill memorializing Henrietta Lacks aims to address underrepresentation in cancer clinical trials.

Keesha Sharp joins Jaime Camil, Cedric the Entertainer and Michael Ealy to push for diversity in cancer trials.

The vaccine demonstrated 95% efficacy in an ongoing Phase III trial.

The front-runner coronavirus vaccine appears to protect people from symptomatic disease.

Some experts want to hold out for a more optimal vaccine. Others believe accepting the best possible vaccine sooner than later is ideal.

A checkpoint inhibitor combination and an antibody-drug conjugate may offer new treatment options.

Jamil Rivers, 42, is the board president of METAvivor, a nonprofit breast cancer organization. She is living with metastatic breast cancer.

None of the four drugs tested in the WHO’s Solidarity trial reduced mortality or duration of hospitalization.

MK-8507, a long-acting NNRTI, will be tested in a weekly regimen with islatravir.

The study asks whether certain approved therapies or late-stage investigational drugs show promise against COVID-19.

The HIV protease inhibitor combination did not speed recovery or reduce the risk of death in a large study.

The treatment reduced coronavirus levels and sped up recovery in a clinical trial.

More diversity would help doctors determine whether coronavirus treatments and vaccines will work for all population groups.